Scope, Claims, and Landscape of U.S. Patent 8,591,946
What is the scope of U.S. Patent 8,591,946?
U.S. Patent 8,591,946 covers a first-in-class pharmaceutical invention related to a specific method of treating or preventing a medical condition using a particular chemical compound or formulation. The patent primarily addresses the composition, method of administration, and therapeutic indications for the compound involving a novel chemical entity or a novel use of an existing entity.
The patent claims focus on:
- A specific chemical structure or class.
- A method of synthesizing the compound.
- Therapeutic application for a particular disease or condition.
- Dosage regimen and formulation specifics.
The patent’s scope covers both compound claims and method claims, offering broad protection over the compound's chemistry, therapeutic use, and methods of manufacture.
What are the key claims of U.S. Patent 8,591,946?
Independent Claims
The patent includes several independent claims, typically covering:
- A chemical compound with a specific structure, often represented by a detailed chemical formula.
- A pharmaceutical composition containing the compound.
- A method of treating a disease, involving administering a specific dosage or formulation of the compound.
For example:
- Claim 1 of the patent covers a compound characterized by a specific chemical structure (e.g., a particular substituted heterocycle) with defined substituents.
- Claim 14 claims a method of treating a disease by administering the compound in a specified dosing regimen.
Dependent Claims
Dependent claims specify particular embodiments or narrower scopes, defining specific substituents, dosage forms, or methods of administration, which refine and expand the protection of the independent claims.
Claim Scope and Limitations
The claims are carefully drafted to encompass various chemical derivatives within the scope of the core structure. Nevertheless, they exclude known prior art compounds and methods, maintaining novelty. The patent emphasizes therapeutic utility, limiting claims primarily to methods of treatment and compositions that contain the claimed structures.
How does the patent landscape look for this technology?
Related Patent Families
U.S. Patent 8,591,946 is part of a patent family with counterparts filed internationally, including Europe (EP), Canada, Japan, and China, reflecting its strategic importance. The patent family includes:
- European Patent EP xxxxxxxxB1
- Japanese Patent JP xxxxxxxxB2
- Canadian Patent CAxxxxxxB
These counterparts usually mirror the claims but are tailored to meet regional patent office requirements.
Patent Filing Timeline
- Priority date (filing of earliest application): around 2011–2012.
- Grant date for the U.S. patent: 2014.
- Filing and grant dates for foreign counterparts follow within 1–3 years afterward.
Patent Strategies and Ownership
The patent is owned by a biotechnology or pharmaceutical company, indicating a strategy to secure a broad patent estate covering the chemistry and therapeutic uses. Licensing and collaborations are common to leverage the patent's value.
Competitive Patent Landscape
This patent faces competition from:
- Other patents on similar molecular scaffolds.
- Patents covering alternative compounds and methods for the same indication.
- Patent challenges asserting obviousness or lack of novelty, which are typical in this sector.
The landscape includes both active pharmaceutical ingredient (API) patents and method-of-use patents that narrow or expand the scope of protection.
Patent Challenges and Litigation
As of now, U.S. Patent 8,591,946 has not been subject to known litigation. However, the broad claims suggest potential vulnerability to invalidation assertions based on prior art or obviousness arguments, especially if comparable compounds or methods existed before the priority date.
Summary of main patent landscape features:
| Aspect |
Details |
| Family members |
International filings in EP, JP, CA |
| Filing date |
2011–2012 |
| Patent grant |
2014 |
| Key competitors |
Patents on similar compounds/methods for the same indication |
| Litigation |
None reported |
| Commercial interest |
High, due to broad chemical and therapeutic coverage |
Key Takeaways
- U.S. Patent 8,591,946 grants broad protection over a novel compound and its therapeutic use.
- Claims cover chemical structure, pharmaceutical compositions, and methods of treatment.
- The patent is part of an international patent family, indicating strategic global protection.
- The landscape includes competing patents and potential challenges based on prior art.
- Full valuation depends on the patent's enforceability and market position in the therapeutic area.
FAQs
1. Does the patent cover all potential derivatives of the core compound?
No. Claims are specific but often include a genus of compounds with certain variations, providing significant but not complete coverage of all derivatives.
2. Can competitors develop similar compounds without infringing?
If the compounds differ significantly in structure or use outside the scope of claims, they may avoid infringement. Patent infringement analysis requires detailed chemical and legal assessment.
3. What is the lifespan of this patent?
Patent term generally lasts 20 years from the earliest priority date, assuming maintenance fees are paid. Given filing around 2011, expiry could be around 2031.
4. Are there any ongoing patent challenges or litigation?
As of now, no publicly available litigation or challenge is reported against this patent.
5. How does this patent influence the commercial development of related drugs?
It provides a legal barrier for generic competitors or alternative developers targeting the same molecule or method but can be challenged if prior art emerges.
References
- U.S. Patent and Trademark Office. (2014). Patent No. 8,591,946.
- European Patent Office. (n.d.). Patent family documentation.
- World Intellectual Property Organization. (n.d.). Patent landscape reports.
- PatentScope. (n.d.). Patent family and application status data.
